• 1.

    Martinez RL, Tovar LJM, 2007. Chromoblastomycosis. Clin Dermatol 25: 188194.

  • 2.

    Queiroz-Tellez F, Esterres P, Perez-Blanco M, Vitale RG, Salgado CG, Bonifaz A, 2009. Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment. Med Mycol 47: 315.

    • Search Google Scholar
    • Export Citation
  • 3.

    Weedon D, van Deurse M, Allison S, Rosendahl C, 2013. Chromoblastomycosis in Australia: an historical perspective. Pathology 45: 489491.

  • 4.

    White TJ, Bruns T, Lee S, Taylor J, 1990. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. PCR Protocols: A Guide to Methods and Applications. New York, NY: Academic Press, 315322.

    • Search Google Scholar
    • Export Citation
  • 5.

    Clinical and Laboratory Standards Institute, 2008. CLSI Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi; Approved Standard. CLSI Document M38-A2. Wayne, PA: Clinical and Laboratory Standards Institute.

    • Search Google Scholar
    • Export Citation
  • 6.

    Chowdhary A, Meis JF, Guarro J, 2014. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi. Clin Microbiol Infect 20 (Suppl 3): 4775.

    • Search Google Scholar
    • Export Citation
  • 7.

    Revankar SG, Sutton DA, 2012. Melanized fungi in human disease. Clin Microbiol Rev 25: 884928.

  • 8.

    Lari HB, Mirani N, Chu DS, 2011. Corneal chromoblastomycosis caused by Cladophialophora carrionii after cataract surgery. J Cataract Refract Surg 37: 963966.

    • Search Google Scholar
    • Export Citation
  • 9.

    Sasano N, Okamoto T, Takahashi T, Suzuki S, 1961. An autopsy case of primary chromoblastomycosis arising from the internal organs. Dark-brown granulomas in the liver and the brain without skin symptoms, observed in a smoking child 3 years old. Tohoku J Exp Med 73: 180190.

    • Search Google Scholar
    • Export Citation
  • 10.

    Sharma NL, Sharma RC, Grover PS, Gupta ML, Sharma AK, Mahajan VK, 1999. Chromoblastomycosis in India. Int J Dermatol 38: 846851.

  • 11.

    Camara-Lemarroy CR, Soto-Garcia AJ, Preciado-Yepez C, Moreno-Hoyos F, Hernandez-Rodriguez PA, Galarza-Delgado DA, 2013. Case of chromoblastomycosis with pulmonary involvement. J Dermatol 40: 746748.

    • Search Google Scholar
    • Export Citation
  • 12.

    Owili DM, Nsanzumuhire H, Ngare W, 1982. Chromoblastomycosis caused by Cladosporium trichoides and associated pulmonary involvement and case report. East Afr Med J 59: 230234.

    • Search Google Scholar
    • Export Citation
  • 13.

    Tintelnot K, von Hunnius P, de Hoog GS, Polak-Wyss A, Gueho E, Masclaux F, 1995. Systemic mycosis caused by a new Cladophialophora species. J Med Vet Mycol 33: 349354.

    • Search Google Scholar
    • Export Citation
  • 14.

    Shigemura T, Agematsu K, Yamazaki T, 2009. Femoral osteomyelitis due to Cladophialophora arxii in a patient with chronic granulomatous disease. Infection 37: 469473.

    • Search Google Scholar
    • Export Citation
 
 
 

 

 

 

 

 

 

First Reported Australian Case of Cladophilophora arxii: Features Consistent with Possible Primary Pulmonary Chromoblastomycosis

View More View Less
  • Department of Infectious Diseases, Royal Darwin Hospital, Darwin, Northern Territory, Australia; National Mycology Reference Centre, SA Pathology at Women's and Children's Hospital, Adelaide, Australia; Department of Infectious Diseases, Royal Darwin Hospital, Darwin, Northern Territory, Australia

We describe the first case of possible pulmonary chromoblastomycosis in the absence of any identified cutaneous lesions in a relatively immunosuppressed man. The causative organism was Cladophialophora arxii, which is a rare pathogen that has only been described as causing human disease two times previously.

Author Notes

* Address correspondence to Anna Brischetto, Department of Infectious Diseases, Royal Darwin Hospital, 105 Rocklands Drive, Tiwi, Northern Territory, Australia, 0810. E-mail: anna.brischetto@gmail.com

Authors' addresses: Anna Brischetto, Infectious Diseases Department, Royal Darwin Hospital, Darwin, Northern Territory, Australia, E-mail: anna.brischetto@gmail.com. Sarah Kidd, SA Pathology, National Mycology Reference Centre, Adelaide, South Australia, Australia, E-mail: sarah.kidd@health.sa.gov.au. Rob Baird, Microbiology, Royal Darwin Hospital, Darwin, Northern Territory, Australia, E-mail: rob.baird@nt.gov.au.

Save